References
- Thompson S. J., Leader K. A., Lastra G. C., Elson C. J. The role of agalactosyl IgG in rodent models of autoimmune disease and in the pathogenesis of rheumatoid arthritis. Abnormalities of IgG Gloeosylalion and Immunological Disorders, S. A. lsenberg, T. W. Rademacher. John Wiley & Sons Ltd. 1996; 131–148
- Hadley A. G., Zupanska B., Kumpel B. M., Pilkington C., Griffiths H. L., Leader K. A., Jones, Booker D. J., Stamps R., Sokol R. J. The glycosylation of red cell autoantibodies and their functional activity in vivo. Br. J. Haematol 1995; 91: 587–594
- Lastra G. C., Thompson S. J., Lemonidis A. S., Elson C. J. Changes in the galactose content of IgG during humoral immune responses. Autoimmunity 1998; 28: 25–30
- Barker R. N., Young R. D., Leader K. A., Elson C. J. Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia. Clin. Exp. Immunol 1999; 117: 449–454
- Rumpel B. M., Wang Y., Griffiths H. L., Hadley A. G., Rook G. A.W. The biological activity of human monoclonal IgG antiD is reduced by beta-galactosidase treatment. Human Antibodies and Hybridomas 1995; 6: 82–88